Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Clinical trial NCT00143234 · COMPLETED
Trial details
- NCT number
- NCT00143234
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 1825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.